查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1923885

医用聚氨酯市场按应用、类型、形式和最终用户划分－2026年至2032年全球预测

Medical Polyurethane Market by Application, Type, Form, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用聚氨酯市场规模将达到 28.5 亿美元，到 2026 年将成长至 31.1 亿美元，到 2032 年将达到 56.4 亿美元，复合年增长率为 10.23%。

关键市场统计数据
基准年 2025 28.5亿美元
预计年份：2026年 31.1亿美元
预测年份 2032 56.4亿美元
复合年增长率 (%) 10.23%

简要概述聚合物化学和加工技术的进步如何与临床要求相结合，从而重新定义医疗设备的设计可能性。

医用级聚氨酯材料凭藉其可调的机械性能和成熟的生物相容性，正在革新各种临床应用领域的医疗设备设计。近年来，材料化学和加工技术的进步使得更薄的薄膜、更柔软的弹性体以及更可靠的长期植入成为可能，同时也能保持其耐灭菌性能。因此，产品设计人员能够满足更广泛的患者需求，从需要抗弯曲性能的柔性导管到需要抗疲劳耐久性的承重假体关节组件。

识别正在重塑医用聚氨酯行业的当代趋势，这些趋势体现在材料创新、监管生命週期要求和供应链韧性的交汇点上。

医用聚氨酯产业正经历一系列变革，其驱动力包括材料科学的创新、临床通讯协定的不断改进以及患者对个人化治疗日益增长的需求。先进的配方技术正在优化弹性体性能和抗疲劳性能，从而实现更小的医疗器材尺寸和更高的患者舒适度。同时，积层製造和精密挤出技术能够实现更复杂的几何形状和更快的原型製作週期，缩短从设计到临床评估的时间。

关税驱动的采购压力正推动策略性供应链重组和营运投资，以保障医疗设备生产的连续性。

影响进口关税和关税表的政策变化正在影响整个供应链的策略采购决策和资本投资模式。在相关政策週期内实施的关税调整提高了原材料采购的成本敏感性，促使采购团队重新评估其供应商组合，并考虑近岸外包和区域内加工方案，以降低到岸成本波动和交货日期不确定性。

基于策略性细分的洞察，将材料化学、加工方式和终端用户期望相结合，能够加速临床应用并实现产品差异化。

对市场区隔的深入了解揭示了技术研发和商业化工作的重点领域。按应用领域划分，目标领域包括循环系统（如心臟瓣膜、支架和血管移植物）、薄膜和片材、整形外科和假体器械、导管和管材以及创伤护理敷料。每种应用对柔软性、耐灭菌性和生物稳定性都有不同的要求，这些要求决定了配方设计和加工方法的选择。依类型划分，聚氨酯分为热塑性聚氨酯和热固性聚氨酯。热塑性树脂通常具有可回收加工性和易于挤出的优点，而热固性系统则透过形成交联网络来增强高温稳定性和长期机械完整性。按形状划分，产品供应形式包括薄膜和片材、液态树脂、粉末和棒材，这些形式决定了合适的製造工艺，例如浸塑成型、挤出成型、浇铸成型和机械加工。按最终用户划分，主要供应目的地包括门诊手术中心、居家医疗和医院。每个终端使用者群体对产品属性的重视程度不同，例如一次性使用、易于操作和长期植入可靠性。

深入了解区域趋势和策略定位，绘製全球主要医疗保健丛集的临床需求概况和製造地

区域趋势正在塑造投资趋势和市场机会，每个地理丛集都反映了不同的法规环境、製造能力和临床应用模式。在美洲，手术量和完善的报销机制推动了对先进导管和管路解决方案的集中需求，从而促进了对本土配製和器械整合的投资。在欧洲、中东和非洲，部分市场的监管协调工作和新兴医疗基础设施正在推动对多功能薄膜和片材解决方案以及能够满足广泛临床需求的成本效益型生产模式的兴趣。在亚太地区，外科手术能力的快速扩张、居家医疗服务的成长以及蓬勃发展的聚合物加工生态系统，正在为本地製造和合作产品开发创造动力。

关键的竞争考察表明，材料创新、监管合规经验和整合製造如何在医用聚氨酯领域创造永续的差异化优势。

医用聚氨酯的竞争优势在于材料专业知识、垂直整合的生产模式、监管能力以及与医疗设备製造商 (OEM) 的合作开发。领先的材料专家投资于专有的化学技术，以实现客製化的弹性体性能和增强的灭菌相容性；而提供从混炼到最终成型的端到端服务的加工商则透过降低 OEM 认证流程的复杂性来创造价值。聚合物製造商与临床创新者之间的策略联盟，透过将材料开发与手术需求和疗效指标结合，加速了转化研究进程。

加强供应链韧性、加速监管合规性以及使材料创新与临床证据产生一致的实用建议

产业领导者应优先考虑平衡策略，在加速下一代材料临床检验的同时，增强供应链韧性。首先，将供应商选择与情境规划结合，以降低单点故障风险，并在不影响生物相容性要求的前提下快速替换原料。其次，透过在早期开发阶段纳入可萃取物和可浸出物测试、灭菌相容性测试以及生命週期安全性评估，使研发蓝图与监管要求保持一致，从而减少返工并加快临床评估进程。第三，投资于能够处理多种规格产品的模组化生产能力，包括薄膜、液态树脂和挤出管材，以优化生产效率并减轻多条产品线的认证负担。

一个稳健的多学科研究框架，结合相关人员访谈、材料评估和供应链图谱分析，能够提供切实可行的见解和检验的建议。

我们的研究途径结合了定性和定量资讯收集、材料评估和法规分析，以确保获得全面的观点。主要研究包括对材料科学家、医疗设备工程师、采购主管和法规专家进行结构化访谈，以了解营运实务和策略意图。次要研究包括查阅公开的法规指南、标准文献和技术出版物，以检验关键应用的测试要求和灭菌限制。

本文全面探讨了材料创新、日益严格的法规和策略性供应链规划将如何共同决定医用聚氨酯应用领域的未来领导地位。

总而言之，医用聚氨酯在各种临床环境中发挥核心作用，协助打造更安全、更舒适、更可靠的医疗设备。材料技术的进步正在催生新的器材架构，而不断完善的法规也正在建立规范，从而提升临床疗效声明的可信度。同时，成本波动和关税变化等外部压力正在加速采购和生产地点的策略性转变，迫使各组织重新思考筹资策略和产能策略。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医用聚氨酯市场（依应用领域划分）

  • 心血管器械
    • 心臟瓣膜
    • 支架
    • 血管移植
  • 薄膜和片材
  • 整形外科和义肢设备
  • 导管和导尿管
  • 伤口敷料

9. 医用聚氨酯市场（按类型划分）

  • 热塑性聚氨酯
  • 热固性聚氨酯

第十章 医用聚氨酯市场（按类型划分）

  • 薄膜和片材
  • 液态树脂
  • 粉末
  • 棒材

第十一章 以最终用户分類的医用聚氨酯市场

  • 门诊手术中心
  • 居家医疗
  • 医院

第十二章 区域性医用聚氨酯市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 医用聚氨酯市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国医用聚氨酯市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国医用聚氨酯市场

第十六章：中国医用聚氨酯市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arkema SA
  • Avient Corporation
  • B. Braun SE
  • BASF SE
  • Bayer AG
  • Cardinal Health, Inc.
  • Covestro AG
  • Dow Inc.
  • DSM Engineering Materials
  • Evonik Industries AG
  • Huntsman Corporation
  • Lubrizol Corporation
  • Merck KGaA
  • Mitsui Chemicals, Inc.
  • PolyOne Corporation
  • Sanyo Chemical Industries, Ltd.
  • Sekisui Chemical Co., Ltd.
  • Stahl Holdings BV
  • Teleflex Incorporated
  • Wanhua Chemical Group Co., Ltd.
Product Code: MRR-7A380DA7C314

The Medical Polyurethane Market was valued at USD 2.85 billion in 2025 and is projected to grow to USD 3.11 billion in 2026, with a CAGR of 10.23%, reaching USD 5.64 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.85 billion
Estimated Year [2026] USD 3.11 billion
Forecast Year [2032] USD 5.64 billion
CAGR (%) 10.23%

A concise orientation to how advances in polymer chemistry and processing are converging with clinical requirements to redefine design possibilities for medical devices

Medical grade polyurethanes are reshaping device design across a range of clinical applications by combining tunable mechanical performance with proven biocompatibility. In recent years, material chemistries and processing techniques have matured to enable thinner films, softer elastomers, and more reliable long term implants while preserving sterilization resilience. As a result, product designers can now address a broader spectrum of patient needs, from flexible tubing and catheters that demand kink resistance to load bearing prosthetic components that require fatigue endurance.

Consequently, stakeholders across the value chain are reorienting product roadmaps around multifunctional performance rather than single attribute improvements. Regulatory expectations are rising in parallel, prompting developers to invest earlier in biocompatibility testing, extractables and leachables studies, and sterilization compatibility assessments. This convergence of material capability and regulatory rigor creates both opportunity and complexity: manufacturers that integrate application specific testing with scalable processing will capture clinical adoption advantages, while those that delay compliance integration will encounter costlier rework and market access delays.

Taken together, the introduction sets the stage for an executive level exploration of where clinical need, polymer innovation, and regulatory pathways intersect, and it frames why strategic decisions made today will determine competitive positioning in the near to medium term.

Distilling the modern forces reshaping the medical polyurethane sector where material innovation meets regulatory lifecycle demands and supply chain resilience

The medical polyurethane landscape is experiencing a sequence of transformative shifts driven by innovation in material science, evolving clinical protocols, and growing expectations for personalized therapies. Advanced formulations are optimizing elastomeric behavior and fatigue resistance, enabling device miniaturization and enhanced patient comfort. Concurrently, additive manufacturing and precision extrusion methods are enabling more complex geometries and faster iteration cycles, which shortens design to clinical evaluation timelines.

At the same time, regulatory frameworks are moving toward lifecycle oriented oversight that emphasizes postmarket surveillance and real world evidence. This regulatory evolution incentivizes manufacturers to invest in robust traceability systems and in-device sensors that can produce outcome data. Meanwhile, supply chain resilience has become a strategic priority; manufacturers are diversifying sourcing and exploring regional processing hubs to reduce lead time variability and exposure to upstream disruptions. Together, these shifts are producing a market dynamic where material performance alone is insufficient; success requires integrated strategies that combine material engineering, regulatory foresight, and supply chain agility.

Therefore, organizations that adopt cross functional collaboration between R&D, regulatory, and operations teams will be best positioned to capitalize on these shifts, accelerate product introductions, and sustain clinical trust.

How tariff driven procurement pressures are prompting strategic supply chain realignments and operational investments to protect device production continuity

Policy changes affecting import duties and tariff schedules are influencing strategic sourcing decisions and capital investment patterns across the supply chain. Tariff adjustments implemented in the referenced policy cycle have increased the cost sensitivity of raw material procurement, prompting procurement teams to reassess supplier portfolios and to evaluate nearshoring and regional processing options to mitigate landed cost volatility and delivery uncertainty.

In response, many manufacturers have accelerated qualification of alternative feedstocks and adopted longer term agreements with regional processors to stabilize input availability. This, in turn, has influenced inventory strategies, with firms opting for more conservative safety stocks and closer integration with contract manufacturers to preserve production continuity. Operationally, some device makers have redirected capital toward domestic compounding and conversion capacity to reduce exposure to cross border duties and to preserve margin.

While tariffs have created short term pressure on cost structures, they have also catalyzed efficiency initiatives and strategic partnerships that reduce dependence on single source geographies. Over time, these adaptations are likely to strengthen resilience and foster closer collaboration between polymer producers and device OEMs, resulting in more predictable supply flows and improved alignment between material specifications and clinical performance requirements.

Strategic segmentation oriented insights that align material chemistry, processing formats, and end user expectations to accelerate clinical adoption and product differentiation

A granular understanding of market segmentation reveals where technical focus and commercialization efforts should be concentrated. Based on Application, the landscape encompasses Cardiovascular Devices including Heart Valves, Stents, and Vascular Grafts, as well as Films and Sheets, Orthopedic and Prosthetic Devices, Tubing and Catheters, and Wound Care Dressings; each application imposes distinct requirements for flexibility, sterilization tolerance, and biostability, which drives formulation and processing choices. Based on Type, the sector divides into Thermoplastic Polyurethane and Thermoset Polyurethane; thermoplastics generally offer recyclable processing and ease of extrusion while thermoset systems provide crosslinked networks that enhance high temperature stability and long term mechanical integrity. Based on Form, product delivery formats encompass Films and Sheets, Liquid Resin, Powder, and Rod, and these forms determine compatible manufacturing routes such as dip molding, extrusion, casting, or machining. Based on End User, the primary delivery channels include Ambulatory Surgical Centers, Homecare, and Hospitals, and each end user segment emphasizes different product attributes such as disposability, ease of handling, or long term implant reliability.

Consequently, commercialization and R&D roadmaps must be tailored to these segmentation nuances. For example, cardiovascular implant materials require exhaustive biocompatibility and fatigue testing and close collaboration with clinicians for in vivo performance validation, whereas materials intended for homecare dressings prioritize cost effective sterilization and user safety. By aligning material selection, processing capability, and regulatory strategy with these segment specific criteria, organizations can accelerate acceptance and reduce iteration cycles during clinical validation.

Regional dynamics and strategic positioning insights that map clinical demand profiles and manufacturing footprints across major global healthcare clusters

Regional dynamics are shaping investment flows and market opportunities, with each geographic cluster reflecting different regulatory environments, manufacturing capabilities, and clinical adoption patterns. In the Americas, there is concentrated demand for advanced catheter and tubing solutions driven by procedural volumes and established reimbursement frameworks, which supports investments in domestic compounding and device integration. In Europe, Middle East and Africa, regulatory harmonization efforts and emerging medical infrastructure in select markets are stimulating interest in versatile film and sheet solutions and in cost effective production models that can serve a broad clinical base. In Asia Pacific, rapid expansion of surgical capacity, growth in homecare services, and an active ecosystem of polymer converters are creating momentum for localized manufacturing and collaborative product development.

These regional patterns are influencing where companies choose to site processing capacity, where they prioritize regulatory submissions, and how they structure distribution networks. Cross regional partnerships and licensing models are increasingly common as firms seek to leverage local clinical expertise while maintaining centralized quality control. Therefore, a regionalized strategy that considers clinical needs, regulatory pathways, and manufacturing footprint will be essential for organizations aiming to scale sustainably across multiple territories.

Critical competitive insights showing how material innovation, regulatory track record, and integrated manufacturing create sustainable differentiation in the medical polyurethane arena

Competitive positioning in medical polyurethane is centered on a combination of material expertise, vertically integrated manufacturing, regulatory competency, and collaborative development with medical device OEMs. Leading material specialists invest in proprietary chemistries that deliver tailored elastomeric behavior and enhanced sterilization compatibility, while converters that offer end to end services from compounding through final forming add value by reducing qualification complexity for OEMs. Strategic alliances between polymer manufacturers and clinical innovators accelerate translational pathways by aligning material development with procedural needs and outcome measures.

Moreover, companies differentiating on quality management and regulatory track record command preferential consideration from device makers that require predictable supply and documentation for clinical submissions. Innovation in additive manufacturing and continuous processing is creating new entrants that combine agile prototyping with focused clinical validation, challenging incumbents to adapt or partner. In parallel, value chain consolidation through selective acquisitions and capacity investments is reshaping competitive dynamics, as firms seek to control critical steps of the conversion process to protect margins and ensure compliance.

Taken together, the competitive field rewards organizations that marry deep polymer science with manufacturing scale and regulatory excellence, and those that can demonstrate verified clinical performance through rigorous testing and real world evidence collection.

Action oriented recommendations to enhance supply chain resilience, accelerate regulatory readiness, and align material innovation with clinical evidence generation

Industry leaders should prioritize a balanced strategy that strengthens supply chain resilience while accelerating clinical validation of next generation materials. First, integrate supplier qualification with scenario planning to reduce single point of failure exposure and to enable rapid substitution of feedstocks without compromising biocompatibility requirements. Second, align R&D roadmaps with regulatory expectations by embedding extractables and leachables testing, sterilization compatibility studies, and lifecycle safety assessments into early stage development to reduce rework and shorten time to clinical evaluation. Third, invest in modular manufacturing capabilities that can scale across forms such as films, liquid resins, and extruded tubing to optimize throughput and reduce qualification burdens for multiple product families.

In addition, pursue collaborative partnerships with device OEMs and clinical research groups to co-develop application specific solutions that deliver validated clinical benefits and generate outcome data. Establishing robust postmarket surveillance and data capture mechanisms will not only meet regulatory imperatives but will also create commercial differentiation through evidence based claims. Finally, evaluate regional processing options and consider escalating nearshore capacity where tariffs and logistics create cost pressure, thereby preserving margin and reducing lead time variability. By implementing these measures, organizations can convert current market pressures into long term competitive advantage.

A robust multi method research framework combining stakeholder interviews, materials evaluation, and supply chain mapping to deliver actionable insights and validated recommendations

The research approach combines qualitative and quantitative intelligence gathering with materials evaluation and regulatory analysis to ensure a holistic perspective. Primary research consisted of structured interviews with material scientists, device engineers, procurement leaders, and regulatory specialists to capture operational realities and strategic intent. Secondary research reviewed publicly available regulatory guidances, standards literature, and technical publications to validate testing requirements and sterilization constraints across key applications.

Technical validation incorporated comparative review of polymer performance characteristics across thermoplastic and thermoset systems, and examined manufacturing method compatibility for different forms including films, resins, powders, and rods. Supply chain mapping identified critical nodes and potential single source exposures, while scenario analysis assessed the operational implications of tariff regimes and regional capacity shifts. Finally, findings were synthesized through cross functional triangulation to ensure that conclusions reflect consistent patterns across clinical needs, material performance, and commercial strategy.

This multi method design ensures that recommendations are grounded in both practical operational considerations and in the technical realities of material behavior and regulatory expectations.

A concluding synthesis of how material innovation, regulatory rigor, and strategic supply planning jointly determine future leadership in medical polyurethane applications

In summary, medical polyurethanes occupy a central role in enabling safer, more comfortable, and more reliable medical devices across a broad range of clinical contexts. Material advances are unlocking new device architectures, and regulatory evolution is instilling a discipline that strengthens the credibility of clinical claims. At the same time, external pressures such as cost volatility and tariff changes are accelerating strategic shifts in sourcing and production footprints, prompting organizations to rethink procurement and capacity strategies.

Consequently, success in this market will depend on an integrated approach that combines material innovation with regulatory foresight, manufacturing flexibility, and collaborative clinical validation. Firms that align technical development with evidence generation and that build resilient, regionally informed supply models will be positioned to lead. Conversely, organizations that treat materials as interchangeable commodities risk slower adoption and greater exposure to compliance setbacks.

The conclusion reinforces that deliberate investment in testing, partnerships, and processing capability will convert current market complexity into long term strategic advantage and sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Polyurethane Market, by Application

  • 8.1. Cardiovascular Devices
    • 8.1.1. Heart Valves
    • 8.1.2. Stents
    • 8.1.3. Vascular Grafts
  • 8.2. Films & Sheets
  • 8.3. Orthopedic & Prosthetic Devices
  • 8.4. Tubing & Catheters
  • 8.5. Wound Care Dressings

9. Medical Polyurethane Market, by Type

  • 9.1. Thermoplastic Polyurethane
  • 9.2. Thermoset Polyurethane

10. Medical Polyurethane Market, by Form

  • 10.1. Films & Sheets
  • 10.2. Liquid Resin
  • 10.3. Powder
  • 10.4. Rod

11. Medical Polyurethane Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Homecare
  • 11.3. Hospitals

12. Medical Polyurethane Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Polyurethane Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Polyurethane Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Polyurethane Market

16. China Medical Polyurethane Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arkema S.A.
  • 17.6. Avient Corporation
  • 17.7. B. Braun SE
  • 17.8. BASF SE
  • 17.9. Bayer AG
  • 17.10. Cardinal Health, Inc.
  • 17.11. Covestro AG
  • 17.12. Dow Inc.
  • 17.13. DSM Engineering Materials
  • 17.14. Evonik Industries AG
  • 17.15. Huntsman Corporation
  • 17.16. Lubrizol Corporation
  • 17.17. Merck KGaA
  • 17.18. Mitsui Chemicals, Inc.
  • 17.19. PolyOne Corporation
  • 17.20. Sanyo Chemical Industries, Ltd.
  • 17.21. Sekisui Chemical Co., Ltd.
  • 17.22. Stahl Holdings B.V.
  • 17.23. Teleflex Incorporated
  • 17.24. Wanhua Chemical Group Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL POLYURETHANE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL POLYURETHANE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ORTHOPEDIC & PROSTHETIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ORTHOPEDIC & PROSTHETIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ORTHOPEDIC & PROSTHETIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TUBING & CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TUBING & CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TUBING & CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY WOUND CARE DRESSINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY WOUND CARE DRESSINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY WOUND CARE DRESSINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOSET POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOSET POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY THERMOSET POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY LIQUID RESIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY LIQUID RESIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY LIQUID RESIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ROD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ROD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY ROD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GCC MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. GCC MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. GCC MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 119. GCC MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. G7 MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. G7 MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 137. G7 MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NATO MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. NATO MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 143. NATO MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA MEDICAL POLYURETHANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA MEDICAL POLYURETHANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)